79 related articles for article (PubMed ID: 29199252)
41. [Selenium in critically ill patients with systemic inflammatory response].
Manzanares Castro W
Nutr Hosp; 2007; 22(3):295-306. PubMed ID: 17612371
[TBL] [Abstract][Full Text] [Related]
42. Clinical rules for phenytoin dosing.
Privitera MD
Ann Pharmacother; 1993 Oct; 27(10):1169-73. PubMed ID: 7818614
[TBL] [Abstract][Full Text] [Related]
43. Vancomycin pharmacokinetic-pharmacodynamic parameters to optimize dosage administration in critically ill children.
Giachetto GA; Telechea HM; Speranza N; Oyarzun M; Nanni L; Menchaca A
Pediatr Crit Care Med; 2011 Nov; 12(6):e250-4. PubMed ID: 21057350
[TBL] [Abstract][Full Text] [Related]
44. Endotoxin immunity and the development of the systemic inflammatory response syndrome in critically ill children.
Stephens RCM; Fidler K; Wilson P; Barclay GR; Mythen MG; Dixon GLJ; Turner MW; Klein NJ; Peters MJ
Intensive Care Med; 2006 Feb; 32(2):286-294. PubMed ID: 16450100
[TBL] [Abstract][Full Text] [Related]
45. [Sepsis in the critically-ill patient].
Christensen VB; Nielsen JS; Tønnesen EK
Ugeskr Laeger; 2007 Feb; 169(8):703-5. PubMed ID: 17313921
[TBL] [Abstract][Full Text] [Related]
46. Systemic inflammatory response syndrome in patients with spinal cord injury: does its presence at admission affect patient outcomes? Clinical article.
Kesani AK; Urquhart JC; Bedard N; Leelapattana P; Siddiqi F; Gurr KR; Bailey CS
J Neurosurg Spine; 2014 Aug; 21(2):296-302. PubMed ID: 24836657
[TBL] [Abstract][Full Text] [Related]
47. An evaluation of systemic inflammatory response syndrome signs in the Sepsis Occurrence In Acutely Ill Patients (SOAP) study.
Sprung CL; Sakr Y; Vincent JL; Le Gall JR; Reinhart K; Ranieri VM; Gerlach H; Fielden J; Groba CB; Payen D
Intensive Care Med; 2006 Mar; 32(3):421-7. PubMed ID: 16479382
[TBL] [Abstract][Full Text] [Related]
48. The effect of urinary and arterial blood pH on the progression of acute kidney injury in critically ill patients with systemic inflammatory response syndrome or sepsis and oliguria.
Dunn WJ; Shimizu T; Santamaria N; Underwood RJ; Woods TL
Aust Crit Care; 2016 Feb; 29(1):41-5. PubMed ID: 26160478
[TBL] [Abstract][Full Text] [Related]
49. Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort study.
Donadello K; Roberts JA; Cristallini S; Beumier M; Shekar K; Jacobs F; Belhaj A; Vincent JL; de Backer D; Taccone FS
Crit Care; 2014 Nov; 18(6):632. PubMed ID: 25416535
[TBL] [Abstract][Full Text] [Related]
50. Significance of lipopolysaccharide-binding protein (an acute phase protein) in monitoring critically ill patients.
Prucha M; Herold I; Zazula R; Dubska L; Dostal M; Hildebrand T; Hyanek J
Crit Care; 2003 Dec; 7(6):R154-9. PubMed ID: 14624690
[TBL] [Abstract][Full Text] [Related]
51. The utility of procalcitonin in critically ill trauma patients.
Sakran JV; Michetti CP; Sheridan MJ; Richmond R; Waked T; Aldaghlas T; Rizzo A; Griffen M; Fakhry SM
J Trauma Acute Care Surg; 2012 Aug; 73(2):413-8; discussion 418. PubMed ID: 22846948
[TBL] [Abstract][Full Text] [Related]
52. [Pharmacokinetic and molecular biological approaches to achieve the safety and effective management of drug therapies].
Iwamoto T
Yakugaku Zasshi; 2007 Jul; 127(7):1077-80. PubMed ID: 17603266
[TBL] [Abstract][Full Text] [Related]
53. Necessity of a loading dose when using vancomycin in critically ill patients.
Ackerman BH; Vannier AM
J Antimicrob Chemother; 1992 Apr; 29(4):460-1. PubMed ID: 1607335
[No Abstract] [Full Text] [Related]
54. [Modern drug therapy in intensive care--concepts? 11th Symposium of the Surgical Study Group for Intensive and Emergency Medicine. Cologne, 6-8 December 1990].
Klin Wochenschr; 1991; 69 Suppl 26():1-240. PubMed ID: 1813702
[No Abstract] [Full Text] [Related]
55. [Evaluation of Pharmacotherapy on Emergency and Intensive Care Medicine: The Influence of Intensity and Duration of Invasion].
Imai T
Yakugaku Zasshi; 2017; 137(12):1427-1430. PubMed ID: 29199252
[TBL] [Abstract][Full Text] [Related]
56. [Influence of systemic inflammatory response syndrome on the pharmacokinetics of vancomycin].
Irikuchi J; Imai T; Yoshida Y; Orii T
Yakugaku Zasshi; 2015; 135(5):745-51. PubMed ID: 25948312
[TBL] [Abstract][Full Text] [Related]
57. Duration of Systemic Inflammatory Response Syndrome Influences Serum Vancomycin Concentration in Patients With Sepsis.
Chuma M; Makishima M; Imai T; Tochikura N; Sakaue T; Kikuchi N; Kinoshita K; Kaburaki M; Yoshida Y
Clin Ther; 2016 Dec; 38(12):2598-2609. PubMed ID: 27836495
[TBL] [Abstract][Full Text] [Related]
58. [Validating the Effectiveness of Switching the Vancomycin TDM Analysis Software Based on the Predictive Accuracy].
Imai S; Yamada T; Ishiguro N; Miyamoto T; Kagami K; Tomiyama N; Niinuma Y; Nagasaki D; Suzuki K; Yamagami A; Kasashi K; Kobayashi M; Iseki K
Yakugaku Zasshi; 2017; 137(9):1185-1192. PubMed ID: 28867705
[TBL] [Abstract][Full Text] [Related]
59. [Involvement of Pharmacists in Medical Care in Emergency and Critical Care Centers].
Imai T; Yoshida Y
Yakugaku Zasshi; 2016; 136(7):967-72. PubMed ID: 27374959
[TBL] [Abstract][Full Text] [Related]
60. Selenium supplementation in the critically ill: posology and pharmacokinetics.
Manzanares W; Hardy G
Curr Opin Clin Nutr Metab Care; 2009 May; 12(3):273-80. PubMed ID: 19333120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
